An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder

BACKGROUND: Despite the current treatments available for panic disorder (PD), as many as one-third of patients have persistent and treatment-resistant panic attacks. Vortioxetine is an approved medicine for major depressive disorder and has been shown to have anxiolytic properties. The purpose of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Anish, Northcutt, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946398/
https://www.ncbi.nlm.nih.gov/pubmed/29760763
http://dx.doi.org/10.1186/s12991-018-0190-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946398/
https://www.ncbi.nlm.nih.gov/pubmed/29760763
http://dx.doi.org/10.1186/s12991-018-0190-6

Ejemplares similares